Stroke Survivors Benefit Significantly From Targeted Spasticity Treatment Using Medtronic, Inc. Drug Pump, Study Finds

MINNEAPOLIS--(BUSINESS WIRE)--A new study of stroke survivors shows that treatment delivered with an implantable drug pump from Medtronic, Inc. (NYSE:MDT) significantly improved patients’ muscle tone, functional independence and quality of life.